BioCardia (NASDAQ:BCDA) just reported results for the second quarter of 2023.
- BioCardia reported earnings per share of -$2.55. This was below the analyst estimate for EPS of -$2.40.
- The company reported revenue of $43,000.
- This was 64.17% worse than the analyst estimate for revenue of $120,000.